Moderna’s COVID-19 vaccine Phase 1 trial successful

Moderna Inc claims its vaccine is fully effective against the new strains
Source - Twitter

On Tuesday, Moderna Inc’s new experimental vaccine for COVID-19 resulted safe for use and provoked faster immune responses in all 45 healthy volunteers in the study. According to the medical team, the volunteers who got two doses of vaccine have already had high levels of virus-antibodies that helped them to recover. All volunteers did not experience any serious side effects, but more than half of them had mild reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. The vaccine maker, Moderna started their first human testing for the coronavirus on March 16.

Read More – Hindustan Times | Reuters | The Dickinson Press | Stat News